
### [NCIT:C3844](http://purl.obolibrary.org/obo/NCIT_C3844)
**Label:** Gallbladder Carcinoma

**Subclasses:** [NCIT:C134675](http://purl.obolibrary.org/obo/NCIT_C134675) (Stage IV Gallbladder Cancer AJCC v8), [NCIT:C5745](http://purl.obolibrary.org/obo/NCIT_C5745) (Gallbladder Signet Ring Cell Carcinoma), [NCIT:C7649](http://purl.obolibrary.org/obo/NCIT_C7649) (Localized Gallbladder Carcinoma), [NCIT:C96890](http://purl.obolibrary.org/obo/NCIT_C96890) (Gallbladder Hepatoid Adenocarcinoma), [NCIT:C96891](http://purl.obolibrary.org/obo/NCIT_C96891) (Gallbladder Cribriform Carcinoma), [NCIT:C134672](http://purl.obolibrary.org/obo/NCIT_C134672) (Stage III Gallbladder Cancer AJCC v8), [NCIT:C4439](http://purl.obolibrary.org/obo/NCIT_C4439) (Stage 0 Gallbladder Cancer AJCC v6 and v7), [NCIT:C5743](http://purl.obolibrary.org/obo/NCIT_C5743) (Gallbladder Papillary Neoplasm with an Associated Invasive Carcinoma), [NCIT:C5744](http://purl.obolibrary.org/obo/NCIT_C5744) (Gallbladder Mucinous Adenocarcinoma), [NCIT:C5740](http://purl.obolibrary.org/obo/NCIT_C5740) (Stage IV Gallbladder Cancer AJCC v6), [NCIT:C9167](http://purl.obolibrary.org/obo/NCIT_C9167) (Undifferentiated Gallbladder Carcinoma), [NCIT:C9166](http://purl.obolibrary.org/obo/NCIT_C9166) (Gallbladder Adenocarcinoma), [NCIT:C43604](http://purl.obolibrary.org/obo/NCIT_C43604) (Gallbladder Adenocarcinoma, Intestinal-Type), [NCIT:C90216](http://purl.obolibrary.org/obo/NCIT_C90216) (Stage I Gallbladder Cancer AJCC v7), [NCIT:C96919](http://purl.obolibrary.org/obo/NCIT_C96919) (Gallbladder Neuroendocrine Carcinoma), [NCIT:C90512](http://purl.obolibrary.org/obo/NCIT_C90512) (Gallbladder Cancer by AJCC v6 Stage), [NCIT:C43605](http://purl.obolibrary.org/obo/NCIT_C43605) (Gallbladder Clear Cell Adenocarcinoma), [NCIT:C9170](http://purl.obolibrary.org/obo/NCIT_C9170) (Gallbladder Squamous Cell Carcinoma), [NCIT:C90218](http://purl.obolibrary.org/obo/NCIT_C90218) (Stage III Gallbladder Cancer AJCC v7), [NCIT:C90217](http://purl.obolibrary.org/obo/NCIT_C90217) (Stage II Gallbladder Cancer AJCC v7), [NCIT:C91229](http://purl.obolibrary.org/obo/NCIT_C91229) (Gallbladder Cancer by AJCC v7 Stage), [NCIT:C96915](http://purl.obolibrary.org/obo/NCIT_C96915) (Gallbladder Adenocarcinoma, Biliary Type), [NCIT:C90219](http://purl.obolibrary.org/obo/NCIT_C90219) (Stage IV Gallbladder Cancer AJCC v7), [NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma), [NCIT:C134663](http://purl.obolibrary.org/obo/NCIT_C134663) (Stage 0 Gallbladder Cancer AJCC v8), [NCIT:C5737](http://purl.obolibrary.org/obo/NCIT_C5737) (Stage I Gallbladder Cancer AJCC v6), [NCIT:C134667](http://purl.obolibrary.org/obo/NCIT_C134667) (Stage II Gallbladder Cancer AJCC v8), [NCIT:C134665](http://purl.obolibrary.org/obo/NCIT_C134665) (Stage I Gallbladder Cancer AJCC v8), [NCIT:C6763](http://purl.obolibrary.org/obo/NCIT_C6763) (Gallbladder Small Cell Neuroendocrine Carcinoma), [NCIT:C7356](http://purl.obolibrary.org/obo/NCIT_C7356) (Gallbladder Adenosquamous Carcinoma), [NCIT:C134660](http://purl.obolibrary.org/obo/NCIT_C134660) (Gallbladder Cancer by AJCC v8 Stage), [NCIT:C96927](http://purl.obolibrary.org/obo/NCIT_C96927) (Gallbladder Mixed Adenoneuroendocrine Carcinoma), [NCIT:C96928](http://purl.obolibrary.org/obo/NCIT_C96928) (Gallbladder Goblet Cell Carcinoid), [NCIT:C96887](http://purl.obolibrary.org/obo/NCIT_C96887) (Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma), [NCIT:C96888](http://purl.obolibrary.org/obo/NCIT_C96888) (Gallbladder Carcinosarcoma), [NCIT:C96921](http://purl.obolibrary.org/obo/NCIT_C96921) (Gallbladder Large Cell Neuroendocrine Carcinoma), [NCIT:C5738](http://purl.obolibrary.org/obo/NCIT_C5738) (Stage II Gallbladder Cancer AJCC v6), [NCIT:C5838](http://purl.obolibrary.org/obo/NCIT_C5838) (Undifferentiated Gallbladder Carcinoma, Spindle and Giant Cell Type), [NCIT:C5739](http://purl.obolibrary.org/obo/NCIT_C5739) (Stage III Gallbladder Cancer AJCC v6), 

**Class expressions from DL-Learner:**

- Thing 54.07%
- [NCIT:C36824](http://purl.obolibrary.org/obo/NCIT_C36824) (Malignant Epithelial Giant Cell) 53.12%
- [NCIT:C36788](http://purl.obolibrary.org/obo/NCIT_C36788) (Giant Epithelial Cell) 53.12%
- [NCIT:C36777](http://purl.obolibrary.org/obo/NCIT_C36777) (Signet Ring Adenocarcinoma Cell) 53.12%
- [NCIT:C25785](http://purl.obolibrary.org/obo/NCIT_C25785) (KRAS Gene) 53.12%
- [NCIT:C18022](http://purl.obolibrary.org/obo/NCIT_C18022) (CDKN2A Gene) 53.12%
- [NCIT:C17756](http://purl.obolibrary.org/obo/NCIT_C17756) (ERBB2 Gene) 53.12%
- [NCIT:C17359](http://purl.obolibrary.org/obo/NCIT_C17359) (TP53 Gene) 53.12%
- [NCIT:C36819](http://purl.obolibrary.org/obo/NCIT_C36819) (Neoplastic Multinucleated Giant Cell) and [NCIT:C36914](http://purl.obolibrary.org/obo/NCIT_C36914) (Atypical Epithelial Cell) 53.12%
- [NCIT:C36819](http://purl.obolibrary.org/obo/NCIT_C36819) (Neoplastic Multinucleated Giant Cell) and [NCIT:C36822](http://purl.obolibrary.org/obo/NCIT_C36822) (Malignant Epithelial Large Cell) 53.12%
- [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) and [NCIT:C36819](http://purl.obolibrary.org/obo/NCIT_C36819) (Neoplastic Multinucleated Giant Cell) 53.12%
- [NCIT:C36788](http://purl.obolibrary.org/obo/NCIT_C36788) (Giant Epithelial Cell) and [NCIT:C36819](http://purl.obolibrary.org/obo/NCIT_C36819) (Neoplastic Multinucleated Giant Cell) 53.12%
- [NCIT:C36779](http://purl.obolibrary.org/obo/NCIT_C36779) (Malignant Epithelial Cell) and [NCIT:C36819](http://purl.obolibrary.org/obo/NCIT_C36819) (Neoplastic Multinucleated Giant Cell) 53.12%
- [NCIT:C36753](http://purl.obolibrary.org/obo/NCIT_C36753) (Neoplastic Epithelial Cell) and [NCIT:C36819](http://purl.obolibrary.org/obo/NCIT_C36819) (Neoplastic Multinucleated Giant Cell) 53.12%
- [NCIT:C36745](http://purl.obolibrary.org/obo/NCIT_C36745) (Abnormal Epithelial Cell) and [NCIT:C36819](http://purl.obolibrary.org/obo/NCIT_C36819) (Neoplastic Multinucleated Giant Cell) 53.12%


